Page last updated: 2024-09-02

tadalafil and Branch Retinal Artery Occlusion

tadalafil has been researched along with Branch Retinal Artery Occlusion in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chalam, KV; Grover, S; Murthy, RK; Perez, L; Priluck, JC	1
Li, AS; Pomeranz, HD	1

Other Studies

2 other study(ies) available for tadalafil and Branch Retinal Artery Occlusion

Article	Year
Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis). JAMA ophthalmology, 2013, Volume: 131, Issue:11 Topics: Acute Disease; Adult; Anemia, Sickle Cell; Carbolines; Familial Primary Pulmonary Hypertension; Female; Fluorescein Angiography; Humans; Hypertension, Pulmonary; Papilledema; Phosphodiesterase 5 Inhibitors; Retinal Artery Occlusion; Tadalafil; Tomography, Optical Coherence	2013
Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2016, Volume: 36, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Phosphodiesterase 5 Inhibitors; Product Surveillance, Postmarketing; Pyrimidines; Retinal Artery Occlusion; Retinal Vein Occlusion; Sildenafil Citrate; Tadalafil; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride	2016

Article

Year

Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis).

JAMA ophthalmology, 2013, Volume: 131, Issue:11

Topics: Acute Disease; Adult; Anemia, Sickle Cell; Carbolines; Familial Primary Pulmonary Hypertension; Female; Fluorescein Angiography; Humans; Hypertension, Pulmonary; Papilledema; Phosphodiesterase 5 Inhibitors; Retinal Artery Occlusion; Tadalafil; Tomography, Optical Coherence

2013

Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2016, Volume: 36, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Phosphodiesterase 5 Inhibitors; Product Surveillance, Postmarketing; Pyrimidines; Retinal Artery Occlusion; Retinal Vein Occlusion; Sildenafil Citrate; Tadalafil; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride

2016